Skip to main content

Incidence of myocarditis and pericarditis considered as separate clinical events over the years and post-SARS-CoV2 vaccination in adults and children

Journal: European Journal of Internal Medicine
Lead Author: Conte et al.
Original date of publication: 09/01/2023
Link: https://pubmed.ncbi.nlm.nih.gov/37311686/

Summary Context

Moderna recipients in Italy were 6 times more likely to develope myocarditis during the high risk period (28 days after shot)

Comments

This article is copyrighted by Health Freedom Defense Fund, Inc.
Visit our Re-post guidelines

This study noted that people younger than 30 at most risk after vaccination for pericarditis.

Abstract or Results, Key Passages

“we may speculate that mRNA SARS-CoV-2 vaccines, like other vaccines, act as a non-specific trigger that in a limited number of susceptible subjects may activate the inflammatory pathways inducing myocarditis and pericarditis.” “The main results of the present study are: 1) a higher risk of both myocarditis and pericarditis was recorded during the first 28 days after mRNA SARS-CoV-2 vaccine dose (both Moderna and Pfizer vaccine)”

Keywords: adverse eventsCardiac eventscovid vaccinemRNAmyocarditis
Full Author List: Edoardo Conte, Olivia Leoni, Enrico Ammirati, Massimo Imazio, Antonio Brucato